Royal Bank of Canada
BMEZ icon

Royal Bank of Canada’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Royal Bank of Canada’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.08M Sell
353,605
-24,894
-7% -$370K ﹤0.01% 2407
2025
Q4 		$5.7M Buy
378,499
+11,793
+3% +$177K ﹤0.01% 2318
2025
Q3 		$5.29M Sell
366,706
-49,923
-12% -$709K ﹤0.01% 2627
2025
Q2 		$5.94M Sell
416,629
-1,177,528
-74% -$16.8M ﹤0.01% 2430
2025
Q1 		$23.8M Buy
1,594,157
+1,220,764
+327% +$19.1M 0.01% 1199
2024
Q4 		$5.38M Sell
373,393
-727,958
-66% -$11.3M ﹤0.01% 2258
2024
Q3 		$17.4M Sell
1,101,351
-68,320
-6% -$1.08M ﹤0.01% 1426
2024
Q2 		$18M Buy
1,169,671
+807,905
+223% +$12.3M ﹤0.01% 1315
2024
Q1 		$5.93M Buy
361,766
+3,650
+1% +$57.6K ﹤0.01% 2053
2023
Q4 		$5.25M Buy
358,116
+51,893
+17% +$724K ﹤0.01% 2199
2023
Q3 		$4.41M Buy
306,223
+60,924
+25% +$950K ﹤0.01% 2190
2023
Q2 		$4.03M Sell
245,299
-11,681
-5% -$190K ﹤0.01% 2262
2023
Q1 		$4.29M Sell
256,980
-9,631
-4% -$155K ﹤0.01% 2198
2022
Q4 		$4.11M Buy
266,611
+2,477
+0.9% +$38.4K ﹤0.01% 2292
2022
Q3 		$3.94M Buy
264,134
+20,934
+9% +$346K ﹤0.01% 2267
2022
Q2 		$4M Buy
243,200
+42,935
+21% +$736K ﹤0.01% 2296
2022
Q1 		$4.02M Sell
200,265
-17,118
-8% -$356K ﹤0.01% 2446
2021
Q4 		$5.51M Sell
217,383
-1,385
-0.6% -$35.8K ﹤0.01% 2315
2021
Q3 		$5.9M Buy
218,768
+21,025
+11% +$602K ﹤0.01% 2186
2021
Q2 		$5.72M Buy
197,743
+62,117
+46% +$1.72M ﹤0.01% 2227
2021
Q1 		$3.57M Buy
135,626
+17,102
+14% +$485K ﹤0.01% 2511
2020
Q4 		$3.4M Buy
118,524
+33,849
+40% +$900K ﹤0.01% 2471
2020
Q3 		$2.02M Buy
84,675
+26,469
+45% +$610K ﹤0.01% 2686
2020
Q2 		$1.22M Buy
58,206
+33,706
+138% +$664K ﹤0.01% 3013
2020
Q1 		$438K Buy
+24,500
New +$472K ﹤0.01% 3731

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Royal Bank of Canada's BMEZ Position: Q1 2026 in Review

Royal Bank of Canada reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 6.6% in Q1 2026, selling an estimated $370K and leaving 353,605 shares worth $5.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

Royal Bank of Canada first reported a position in BMEZ in Q1 2020 and has held it in 25 quarters since. The position peaked at $23.8M in Q1 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Royal Bank of Canada held 353,605 shares of BlackRock Health Sciences Trust II worth $5.08M as of Q1 2026.
  • Royal Bank of Canada sold 24,894 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $370K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2407 holding.
  • Royal Bank of Canada first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and has held it in 25 quarters since.
  • Royal Bank of Canada's BlackRock Health Sciences Trust II position peaked at $23.8M in Q1 2025.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.